How Does Preclinical Toxicity Testing Influence Drug Development?
The outcomes of preclinical toxicity testing play a pivotal role in the drug development process. Positive results can lead to the progression of a drug candidate into clinical development, while negative results may prompt further research or discontinuation. These tests help in risk assessment and management, ensuring that only safe and potentially efficacious compounds move forward. Additionally, the data generated guides regulatory submissions and helps in securing approval from agencies like the FDA or the European Medicines Agency.
